Zoetis (ZTS) Q4 2023 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/02/13/zoetis-zts-q4-2023-earnings-call-transcript/?source=iedfolrf0000001
Feb 13, 2024 - ZTS earnings call for the period ending December 31, 2023.
0
4 Magnificent Stocks I'm Done Waiting on a Dip for in 2024 -- but I'm Not Buying Them Hand Over Fist, Either
https://www.fool.com/investing/2024/01/20/4-magnificent-stocks-im-done-waiting-on-a-dip-for/?source=iedfolrf0000001
Jan 20, 2024 - These stocks never seem to go on sale. Here's why I'm buying them anyway.
0
1 Magnificent S&P 500 Dividend Stock Down 23% to Buy Right Now
https://www.fool.com/investing/2024/02/26/1-magnificent-sp-500-dividend-stock-down-23-to-buy/?source=iedfolrf0000001
Feb 26, 2024 - Buoyed by megatrends in animal healthcare, this stock makes for an excellent holding in almost any portfolio.
0
GRFS vs. ZTS: Which Stock Is the Better Value Option?
https://www.zacks.com/stock/news/2195001/grfs-vs-zts-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2195001
Dec 07, 2023 - GRFS vs. ZTS: Which Stock Is the Better Value Option?
0
GRFS or ZTS: Which Is the Better Value Stock Right Now?
https://www.zacks.com/stock/news/2202748/grfs-or-zts-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2202748
Dec 27, 2023 - GRFS vs. ZTS: Which Stock Is the Better Value Option?
0
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
https://www.zacks.com/stock/news/2207964/these-2-medical-stocks-could-beat-earnings-why-they-should-be-on-your-radar?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2207964
Jan 09, 2024 - Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
0
GRFS vs. ZTS: Which Stock Is the Better Value Option?
https://www.zacks.com/stock/news/2209634/grfs-vs-zts-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2209634
Jan 12, 2024 - GRFS vs. ZTS: Which Stock Is the Better Value Option?
0
Will Sage Therapeutics, Inc. (SAGE) Report Negative Earnings Next Week? What You Should Know
https://www.zacks.com/stock/news/2222623/will-sage-therapeutics-inc-sage-report-negative-earnings-next-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2222623
Feb 07, 2024 - Sage Therapeutics, Inc. (SAGE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
https://www.zacks.com/stock/news/2223944/how-to-find-strong-medical-stocks-slated-for-positive-earnings-surprises?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2223944
Feb 09, 2024 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
0
Compared to Estimates, Zoetis (ZTS) Q4 Earnings: A Look at Key Metrics
https://www.zacks.com/stock/news/2225588/compared-to-estimates-zoetis-zts-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2225588
Feb 13, 2024 - The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Pages: 12
Page 1